Atrial Fibrillation Trial, Recruiting NCT07095959 Sponsor: Beijing Anzhen Hospital Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07095959
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes) and experience symptoms such as palpitations, dizziness, fatigue, shortness of breath, or chest discomfort
  • This would be your first time having a procedure (ablation) to treat your atrial fibrillation
  • At least one episode of your irregular heartbeat lasting longer than 30 seconds has been recorded by a heart monitor (such as an ECG or Holter monitor) within the past 12 months
  • You are willing and able to understand the study, agree to be randomly assigned to a treatment approach, attend follow-up appointments, and sign a consent form

Who may not be able to join:

  • You have been diagnosed with a type of atrial fibrillation that is persistent (does not stop on its own) or has lasted longer than 7 days
  • You have a blood clot inside your heart
  • You are unable to take blood-thinning medications, including if you have ever had a serious reaction to a blood thinner called heparin that caused low platelet counts
  • Your irregular heartbeat is caused by a temporary or treatable condition such as an electrolyte imbalance, thyroid problem, or other non-heart-related cause
  • You have had a heart attack, a procedure to open blocked heart arteries, or heart bypass surgery within the past 3 months
  • You have had a stroke or a mini-stroke (TIA) within the past 3 months
  • You have previously had heart surgery or any procedure involving the left side of your heart, such as a prior ablation or repair of a hole in the heart
  • You have a history of serious heart valve disease, a heart defect present from birth, or certain conditions that cause the heart muscle to thicken or enlarge abnormally
  • A heart scan (ultrasound) within the past 12 months showed that a particular chamber of your heart (the left atrium) is larger than a certain size (confirm with trial site)
  • You have had an organ transplant, are being evaluated for one, have a life expectancy of less than one year, have uncontrolled cancer, or are pregnant, breastfeeding, or planning to become pregnant
  • The trial team has determined for any other reason that you are not suitable to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 010-81992280

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Anzhen Hospital
Registry
ClinicalTrials.gov
Start date
31 July 2025
Est. completion
10 July 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Any atrial arrhythmias lasting ≥30s without AAD during 12 months after procedure excluding the 2-months blanking period

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov